Literature DB >> 19146800

The BEAUTIFUL study: is heart rate reduction a new therapeutic principle?

Frank Enseleit, Frank Ruschitzka.   

Abstract

Year:  2009        PMID： 19146800     DOI： 10.1007/s11906-009-0009-6

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  14 in total

1.  Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials.

Authors:  J K Kjekshus
Journal:  Am J Cardiol       Date:  1986-04-25       Impact factor: 2.778

2.  Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.

Authors:  Ariel Diaz; Martial G Bourassa; Marie-Claude Guertin; Jean-Claude Tardif
Journal:  Eur Heart J       Date:  2005-03-17       Impact factor: 29.983

3.  Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption.

Authors:  U E Heidland; B E Strauer
Journal:  Circulation       Date:  2001-09-25       Impact factor: 29.690

Review 4.  Resting heart rate in cardiovascular disease.

Authors:  Kim Fox; Jeffrey S Borer; A John Camm; Nicolas Danchin; Roberto Ferrari; Jose L Lopez Sendon; Philippe Gabriel Steg; Jean-Claude Tardif; Luigi Tavazzi; Michal Tendera
Journal:  J Am Coll Cardiol       Date:  2007-08-13       Impact factor: 24.094

5.  Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies.

Authors:  A R Dyer; V Persky; J Stamler; O Paul; R B Shekelle; D M Berkson; M Lepper; J A Schoenberger; H A Lindberg
Journal:  Am J Epidemiol       Date:  1980-12       Impact factor: 4.897

6.  Heart rate and cardiovascular mortality: the Framingham Study.

Authors:  W B Kannel; C Kannel; R S Paffenbarger; L A Cupples
Journal:  Am Heart J       Date:  1987-06       Impact factor: 4.749

Review 7.  Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.

Authors:  Dario DiFrancesco; John A Camm
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Authors:  Kim Fox; Ian Ford; P Gabriel Steg; Michal Tendera; Roberto Ferrari
Journal:  Lancet       Date:  2008-08-29       Impact factor: 79.321

9.  Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.

Authors:  Kim Fox; Ian Ford; P Gabriel Steg; Michal Tendera; Michele Robertson; Roberto Ferrari
Journal:  Lancet       Date:  2008-08-29       Impact factor: 79.321

10.  Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology.

Authors:  Kim Fox; Maria Angeles Alonso Garcia; Diego Ardissino; Pawel Buszman; Paolo G Camici; Filippo Crea; Caroline Daly; Guy De Backer; Paul Hjemdahl; José Lopez-Sendon; Jean Marco; João Morais; John Pepper; Udo Sechtem; Maarten Simoons; Kristian Thygesen; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; John Camm; Veronica Dean; Jaap Deckers; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; João Morais; Ady Osterspey; Juan Tamargo; José L Zamorano
Journal:  Eur Heart J       Date:  2006-05-30       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.